Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 15/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 13/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 11/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3712314 | 0.87 | SLC6A3 (0.46) | SLC6A4SLC6A3SLC6A2HDAC3HDAC1 | |
| SCHEMBL3709523 | 0.84 | HDAC3 (0.39) | SLC6A4SLC6A3SLC6A2HDAC3HDAC1 | |
| SCHEMBL27734550 | 0.84 | SLC6A3 (0.62) | SLC6A4SLC6A3SLC6A2HDAC3HDAC1 | |
| SCHEMBL3718210 | 0.82 | DRD2 (0.42) | SLC6A4SLC6A3SLC6A2KCNH2 | |
| SCHEMBL3707150 | 0.80 | SLC6A3 (0.47) | SLC6A4SLC6A3SLC6A2HDAC3HDAC1 | |
| SCHEMBL3712760 | 0.79 | SLC6A3 (0.41) | SLC6A4SLC6A3SLC6A2HDAC3HDAC1 | |
| SCHEMBL3709501 | 0.79 | HTR2C (0.42) | SLC6A4SLC6A3SLC6A2HDAC6 | |
| SCHEMBL3705259 | 0.78 | CTSD (0.37) | SLC6A4SLC6A3SLC6A2HDAC3HDAC1 | |
| SCHEMBL4520209 | 0.77 | SLC6A4 (0.46) | SLC6A4SLC6A3SLC6A2CYP2D6 | |
| SCHEMBL3705030 | 0.77 | SLC6A4 (0.47) | SLC6A4SLC6A3SLC6A2HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2391603-A1 | AROYLAMINO - AND HETEROAROYLAMINO-SUBSTITUTED PIPERIDINES AS GLYT-1 INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2011-12-07 | — | — | EP | disclosed |
| WO-2010086251-A1 | AROYLAMINO - AND HETEROAROYLAMINO-SUBSTITUTED PIPERIDINES AS GLYT-1 INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2010-08-05 | — | — | WO | disclosed |